Author

J. D. Kandler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

D. Bojkova· 3 shared J. Cinatl· 3 shared M. Michaelis· 3 shared M. N. Wass· 3 shared S. Ciesek· 3 shared T. Rothenburger· 3 shared M. Bechtel· 2 shared D. Jonigk· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

D. Bojkova

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Repurposing of the antibiotic nitroxoline for the treatment of mpox

D. Bojkova, N. Zoeller, M. Tietgen, K. Steinhorst, M. Bechtel, T. Rothenburger, J. D. Kandler, J. Schneider, V. M. Corman, S. Ciesek, H. F. Rabenau, M. N. Wass, S. Kippenberger, S. Göttig, M. Michaelis, J. Cinatl

This study shows nitroxoline, an antibiotic, inhibits mpox virus replication and remains effective against tecovirimat-resistant strains, suggesting it as a repurposing candidate for mpox treatment.

bioRxiv · Dec 29, 2022Microbiology

Omicron-induced interferon signalling prevents influenza A virus infection

D. Bojkova, M. Bechtel, T. Rothenburger, J. D. Kandler, L. Hayes, R. Olmer, U. Martin, D. Jonigk, S. Ciesek, M. N. Wass, M. Michaelis, J. Cinatl

This study shows Omicron variants induce interferon responses in human cells, protecting against influenza A virus super-infection, while Delta does not.

bioRxiv · Sep 6, 2022 · PreprintMicrobiology

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants

D. Bojkova, R. Stack, T. Rothenburger, J. D. Kandler, S. Ciesek, M. N. Wass, M. Michaelis, J. Cinatl

This study evaluates the antiviral efficacy of interferon-beta combined with antiviral drugs against SARS-CoV-2 variants, finding synergistic effects with certain drugs against specific variants.

bioRxiv · Jul 22, 2022Microbiology